<DOC>
	<DOCNO>NCT01212900</DOCNO>
	<brief_summary>Background : - Atherosclerosis ( thicken artery wall cause cholesterol deposit ) commonly occur heart vessel carotid ( neck ) arteries adult . This often present individual high cholesterol level blood . These patient usually treat cholesterol lower medication ( statin ) along modification diet exercise . Researchers interested investigate new approach include magnetic resonance imaging ( MRI ) compute tomography ( CT ) image study detect blood vessel blockage would otherwise detect cholesterol level risk factor heart disease . Objectives : - To measure atherosclerosis heart vessel carotid artery use image test ( compute tomography ( CT ) magnetic resonance imaging ( MRI ) ) standard treatment cholesterol lower medication ( statin ) Eligibility : - Healthy individual least 55 year age candidate therapy low blood cholesterol level . Design : - This study involve one screen visit seven study visit period 2 year . - Participants screen physical examination medical history , well blood sample test ensure safe CT MRI scan . Participants provide information current medication , dietary habit , smoke status , alcohol caffeine intake , level physical activity . - Participants divide two group . One group receive standard dos medication low cholesterol accord current treatment guideline , group MRI scan carotid artery CT scan heart determine best medication dose level . - Visits 3 5 schedule 3 , 6 , 9 month visit 2 . During visit , researcher monitor possible side effect may change adjust medication dos . - At visit 6 , participant MRI scan carotid artery , physical examination , blood test . Medications may change adjust . - At visit 7 , participant blood test , medication may change adjust . - At final visit , participant MRI CT scan carotid artery heart , respectively , well final physical examination blood test .</brief_summary>
	<brief_title>Randomized Trial Imaging Versus Risk Factor-Based Therapy Plaque Regression</brief_title>
	<detailed_description>The overall aim proposal compare effectiveness image guide approach lipid lower standard therapy guide clinical risk factor blood lipid level . Men woman age 55 candidate statin therapy randomize usual cholesterol lower care , care guide MRI image carotid artery . Participants randomized second , image guide , group assign LDL cholesterol target accord degree atherosclerosis see MRI . The study endpoint total degree plaque regression see , dosage statin drug require achieve reduction , rate cardiovascular event . FDG-PET hypothesize enable visualization anti-inflammatory effect statins likely occur anatomic regression plaque demonstrate MRI . A pilot substudy conduct explore relationship . A subgroup patient participate main study ask participate FDG PET image . The purpose pilot study determine FDG avid lesion undergo great degree morphologic regression therapy control reduction LDL cholesterol dosage statin require achieve target . Although contrast-enhanced coronary CT angiography ( CTA ) multidetector compute tomography ( MDCT ) use extensively characterize coronary artery plaque composition , little data regard reproducibility . A recent study demonstrate excellent reproducibility technique study perform use old 64 detector row CT scanners2 . A pilot substudy conduct study reproducibility coronary CT angiography use new generation 320 detector row CT scanner .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>INCLUSION CRITERIA : A . Men Women great equal 55 year age B . Candidates lipid lower therapy NCEP ATP III guideline without contraindication statin therapy C. Willing modify therapy enroll study D. Willing travel NIH followup visit . E. Able understand sign inform consent F. Lab Eligibility parameter : eGFR &gt; 45 mL/min/m2 For age &gt; 60 test GFR within 1 week prior contrast ; For age le equal 60 test within 4 week INCLUSION CRITERIA FOR THE PET SUBSTUDY : Participants participate CT Reproducibility study eligible . INCLUSION CRITERIA FOR THE REPRODUCIBILITY SUBSTUDY : Patients select one RR interval initial CT scan le 10.5 mSv estimate radiation dosage participate PET Substudy . EXCLUSION CRITERIA : A. Ineligibility MR image due : Previous pacemaker implantation Automatic implantable cardioverterdefibrillator ( AICD ) Metal implant ferromagnetic device , Foreign material B. Claustrophobia C. Contraindication allergy statin medication . D. Current statin therapy maximum dosage permit per study protocol . E. Use fibrates , ezetimibe , niacin , bile acid bind agent within 6 month screen visit . F. Pregnancy nursing . G. Liver failure define clinically laboratory data . H. Mental , neurologic social condition prevent understanding rationale , procedure , risk potential benefit associate trial . I . Any condition precludes safety MRI and/or CT image per researcher evaluation . EXCLUSION FOR PARTICIPATION FOR GADOLINUIM CONTRAST . PARTICIPANTS MAY STILL UNDERGO ALL OTHER STUDY EVALUATIONS . ( Inclusive exclusion criterion ) : 1 . Allergy gadolinium scan use contrast ; eligible noncontrast scan . 2 . Acute renal failure , renal transplant , dialysis renal failure ( eGFR &lt; 45 mL/min/m2 and/or clinically diagnose ) . 3 . Individuals history liver transplant severe liver disease. &lt; TAB &gt; 4 . Individuals hemoglobinopathy severe asthma . EXCLUSION FOR PARTICIPATION FOR IODINATED CONTRAST . PARTICIPANTS MAY STILL UNDERGO ALL OTHER SUDY EVALUATIONS . Prior hypersensitivity reaction iodinate contrast injection , renal dysfunction ( define eGFR &lt; 45 mL/min/ m2 ) current clinical diagnosis renal failure . EXCLUSION CRITERIA FOR THE PET SUBSTUDY : Patients unable unwilling comply physical activity restriction fast 12 hour prior FDG PET scan exclude . Due need dietary manipulation maintenance strict glycemic control exclude diabetic patient initial study sample . Blood glucose measurement injection must within normal limit , less 200 mg/dL ( 11 mmol/L ) . EXCLUSION CRITERIA FOR THE REPRODUCIBILITY Patients one RR interval initial CT scan . Patients participate PET Substudy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 22, 2017</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Cardiac MRI</keyword>
	<keyword>Cardiac CT</keyword>
	<keyword>Cholesterol</keyword>
</DOC>